Can-Fite BioPharma

CANFNYSE Israel Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$4.799 M

$2.24 +0.00%

Close of 18 Sept 2026

Revenue

$405.0K

#3544 by revenue

Earnings

-$9.83M

Loss-making

Shares outstanding

2,618,425

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#461Processa PharmaceuticalsPCSA$5.48M
#462PulmatrixPULM$5.26M
#463Can-Fite BioPharmaCANF$4.80M
#464Lakewood-Amedex BiotherapeuticsLABT$4.72M
#465Dermata TherapeuticsDRMA$4.67M

What if Can-Fite BioPharma were worth as much as…

Open the what-if tool →

Gold $30.4T

$14,182,868

Per share 6,331,637× higher

Bitcoin $1.64T

$763,590.24

Per share 340,889× higher

Nvidia $5.36T

$2,500,159

Per share 1,116,142× higher

Or at a round number

$10.0M $20.0M $50.0M $100.0M

Where these numbers come from

Share counts and financials for Can-Fite BioPharma are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 19 Sept 2026. Read the methodology.